THOMAS SHANDS: Open Payments
NPI 1346247798 · NEW ALBANY, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$276 in 16 payments from 5 companies in 2025. Trend: 2023 $523 · 2024 $396 · 2025 $276
Food & beverage: $260Education: $16
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $94 |
| AstraZeneca Pharmaceuticals LP | 4 | $63 |
| Novo Nordisk Inc | 3 | $48 |
| Amgen Inc. | 3 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
Products named: MOUNJARO, EVENITY, Ozempic, AIRSUPRA, TRINTELLIX, FARXIGA, BREZTRI.
Industry payments across MS — which companies pay providers there.
